STERILINE at PHARMA PRO&PACK EXPO 2025
With its own branch already established in India, Steriline confirms the importance of the Indian and of Asian markets in general for its growth and development
Steriline, a company highly specialised in the production of complete aseptic packaging lines for injectables and ophthalmic products for global pharmaceutical companies, will exhibit for the second consecutive year at Pharma Pro&Pack Expo, an important trade show in India dedicated to machinery for the treatment and packaging of products in the pharmaceutical and biotechnological sectors.
The company will be pleased to welcome visitors from 18 to 20 September 2025 at Stand No. H6-D45, Hall 6 of the Hitex Exhibition Centre in Hyderabad.
Steriline, which has been present in India directly with its own subsidiary since 2022, considers the Indian and Asian market to be very important for its growth and continuously focuses on developing dedicated solutions that meet the needs of the local pharmaceutical industry, while working towards a more sustainable future.
The Indian headquarters of Steriline is growing and has nearly doubled the number of employees since it opened, with a fair balance between technical professionals (dedicated mainly to line installation and after-sales assistance) and commercial staff, who are focused on selling solutions and services.
“We are proud to be participating again with a stand in the Pharma Pro&Pack Expo,” says Federico Fumagalli, Steriline’s CSO. “For Steriline, India is a fundamental market, both for historical and obviously strategic reasons, as demonstrated by our opening an office in Mumbai three years ago and by the continuous investment the company is making in this direction.”
Pharma Pro&Pack Expo therefore represents an important opportunity for Steriline to meet with the Indian pharmaceutical sector – and not only that. “The strategic position of the trade fair, close to a major pharmaceutical industry district and centres of excellence, both technologically and in terms of innovative therapies, represents real added value for us,” stresses Filippo Parini, Head of Sales India for Steriline.
“The venue certainly allows us to make contact with many companies and to speak directly with the representatives of the main functions of each company, delving thoroughly into their technological and functional needs,” concludes Chiranjeevi Kondapaka, CEO of Steriline Asia. “With this information, Steriline can then work even more precisely and punctually to meet the specific needs of its stakeholders, be they current or potential customers.”
About Steriline
Steriline is a well-established European manufacturer, highly specialised in the production of complete lines for the aseptic processing of injectable and ophthalmic products, at the service of pharmaceutical companies worldwide.
Steriline was founded in 1989 in the Lake Como area (Italy), where its headquarters and manufacturing facilities are still based. With operations in over 50 countries around the world, Steriline has a network of approximately 400 people, including direct employees and external partners, in addition to 40 local sales representatives. Exports represent more than 90% of Steriline’s turnover, with over 2,000 machines installed throughout Asia, Europe and the U.S.A.
Steriline develops, manufactures and supplies a comprehensive range of solutions, including both mechanical and robotic applications for aseptic processing. These applications are consistent with vials, ampoules, cartridges and syringes and can handle toxic or non-toxic products in both liquid and powder form. Steriline’s complete lines include equipment ranging from washing machines, depyrogenation tunnels, filling and capping machines, to external decontamination machines and barrier systems such as LAF, oRABS, cRABS and isolators.
For more information on Steriline, visit www.steriline.it or the company profile on LinkedInorInstagram.